Abstract: The invention relates to a process for treating, with a plasma, a composition comprising at least a first compound and a second compound, characterized in that said process comprises at least: generating, within an enclosure, a non-equilibrium plasma flow from a gas present in said enclosure, and treating the composition contained in said enclosure with said non-equilibrium plasma flow so as to extract at least a portion of said first compound.

Abstract: The present invention relates to non-naturally occurring anti-bacterial peptides. More specifically the peptides can be used to treat multi-drug resistant bacterial infections. In addition, the present invention provides methods for producing anti-bacterial peptides.

Abstract: Aspects of the invention concern non-naturally occurring molecules capable of downregulating the amount or biological activity specifically of mutant or variant forms of a protein, as well applications thereof.

Abstract: The present methods and systems generally relate to the biomedical field and relate to subfields of computational biology and bioinformatics. More, specifically the invention provides an artificial intelligence algorithm which can identify aggregation prone regions, particularly amyloid sequences in a protein.

Abstract: The invention relates to a process for selectively and continuously extracting a series of desired species from a matrix, comprising the steps of:—injecting a plasma (310) in an extraction chamber by means of a plasma torch,—continuously monitoring (320) the excited elements extracted from the matrix and contained in the plasma by optical emission spectroscopy, and for each species of the series,—setting a distance (330) between the support and the plasma torch, and the composition of the injected plasma as a function of the monitored excited elements so that only one desired species of the series of species is being extracted from the matrix under molecular form, and—providing (400) a plate in the extraction chamber, exterior to the plasma, causing collection of molecules comprising said desired species by deposition onto the surface of the plate.

Abstract: The present invention provides non-natural molecules which comprise a peptide part able to stop the amyloid aggregation which is fused to a moiety which stimulates the proteasomal degradation pathway in the cell. Non-natural molecules of the invention are useful to treat human and veterinary pathological aggregation disorders.

Abstract: The invention relates to a heat exchanger for vaporizing a coolant fluid by heat exchange with a calorigenic fluid, said exchanger comprising several parallel plates defining a plurality of passages between them which are suitable for the coolant fluid or calorigenic fluid to flow, a first wave and a second wave extending between two successive plates so as to define a plurality of channels within the same passage, said first and second waves comprising two adjacent edges, at least one assembly member extending from one edge to the other so as to connect the waves to one another. According to the invention, the assembly member is forcibly engaged in at least one part of a channel of the first wave on one hand, and in at least one part of a channel of the second wave on the other hand.

Abstract: Aspects of the invention concern non-naturally occurring molecules configured to form an intermolecular beta-sheet with a human RAS protein mutated at position 12 or 13 and substantially not with wild-type human RAS protein, as well therapeutic applications thereof.

Abstract: Aspects of the invention concern non-naturally occurring molecules configured to form an intermolecular beta-sheet with a human RAS protein, as well therapeutic applications thereof.

Abstract: The invention relates to methods of leavening a batter or dough of a bakery product comprising the steps of: providing a batter or dough comprising an isolated glutamate decarboxylase enzyme or an isolated aspartate decarboxylase enzyme and respectively glutamic acid or a salt thereof or aspartic acid or a salt thereof in a concentration of at least 0.005 mole glutamic acid/kg dough or batter, wherein the batter or dough does not contain added yeast or sourdough bacteria.

Abstract: A multi-core architecture including: a plurality of processing devices, each processing device including a single processor or a cluster of processors; and a lock manager associated with each processing device, each lock manager being configured to: store a first data value indicating of whether or not it currently owns a first lock, the first lock authorizing access to a resource; and permit an owner of the first lock to be determined by one or more lock managers by broadcasting, over an interconnection network to each of the other lock managers, at least one message.

Abstract: The present application belongs to the field of functional peptides and more particularly to the field of controlled protein aggregation. The invention discloses molecules of a peptide structure as defined in the claims and methods of using such molecules for therapeutic applications and for diagnostic uses, as well as in other applications such as in the agbio field and in industrial biotechnology. The molecules can be used for curing and/or stabilizing infections such as bacterial,fimgal and viral diseases, but are also useful in non-infectious human and veterinary diseases. The molecules can also be used for the detection of protein biomarkers and for the prognosis and diagnosis of a variety of diseases.

Abstract: A lubrication system for a roller chain. The lubrication system provides a lubricant reservoir, at least one piston pump, and synchronization means. The synchronization means has engaging means dedicated to mechanically mesh with roller chain in motion, and actuating means fastened in motion with the synchronization means the actuating means being in constant mechanical cooperation with a piston pump.

Abstract: The present invention relates to non-naturally occurring anti-bacterial peptides. More specifically the peptides can be used to treat multi-drug resistant bacterial infections. In addition, the present invention provides methods for producing anti-bacterial peptides.

Abstract: The invention relates to a heat exchanger for vaporizing a coolant fluid by heat exchange with a calorigenic fluid, said exchanger comprising several parallel plates defining a plurality of passages between them which are suitable for the coolant fluid or calorigenic fluid to flow, a first wave and a second wave extending between two successive plates so as to define a plurality of channels within the same passage, said first and second waves comprising two adjacent edges, at least one assembly member extending from one edge to the other so as to connect the waves to one another.

Abstract: A method for manufacturing a decorative lining (HD) for a vehicle interior element (EH) is disclosed. Said method involves: —step (i) wherein the size of at least one edge (B11, B12) of two leather parts (PC1, PC2) is reduced on an inner face (FI1) and each reduced-size edge is folded over to form a fold (R1, R2) on each leather part (PC1, PC2); and —step (ii) wherein the leather parts (PC1, PC2) as well as a decorative insert (ID) that is inserted between the two leather parts (PC1, PC2) are coupled to the vehicle interior element (EH) by placing two edges (B21, B22) underneath the folds (R1, R2).

Abstract: A multi-core architecture including: a plurality of processing devices, each processing device including a single processor or a cluster of processors; and a lock manager associated with each processing device, each lock manager being configured to: store a first data value indicating of whether or not it currently owns a first lock, the first lock authorizing access to a resource; and permit an owner of the first lock to be determined by one or more lock managers by broadcasting, over an interconnection network to each of the other lock managers, at least one message.

Abstract: A method for manufacturing a decorative lining (HD) for a vehicle interior element (EH) is disclosed. Said method involves: step (i) wherein the size of at least one edge (B11, B12) of two leather parts (PC1, PC2) is reduced on an inner face (FI1) and each reduced-size edge is folded over to form a fold (R1, R2) on each leather part (PC1, PC2); and step (ii) wherein the leather parts (PC1, PC2) as well as a decorative insert (ID) that is inserted between the two leather parts (PC1, PC2) are coupled to the vehicle interior element (EH) by placing two edges (B21, B22) underneath the folds (R1, R2).

Abstract: The present invention belongs to the field of functional proteomics and more particularly to the field of protein aggregation. The invention discloses a method for interfering with the function of a target protein and uses a non-naturally, user-designed molecule, designated as interferor, that has a specificity for a target protein and which induces aggregation upon contact with said target protein. The present invention also discloses such interferor molecules and their use in agrobiotech applications.

Abstract: The invention relates to a process for selectively and continuously extracting a series of desired species from a matrix, comprising the steps of:—injecting a plasma (310) in an extraction chamber by means of a plasma torch,—continuously monitoring (320) the excited elements extracted from the matrix and contained in the plasma by optical emission spectroscopy, and for each species of the series,—setting a distance (330) between the support and the plasma torch, and the composition of the injected plasma as a function of the monitored excited elements so that only one desired species of the series of species is being extracted from the matrix under molecular form, and—providing (400) a plate in the extraction chamber, exterior to the plasma, causing collection of molecules comprising said desired species by deposition onto the surface of the plate.